ATNF
Price
$0.88
Change
-$0.12 (-12.00%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
3.18M
QNRX
Price
$0.25
Change
-$0.04 (-13.79%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
6.02M
Ad is loading...

ATNF vs QNRX

Header iconATNF vs QNRX Comparison
Open Charts ATNF vs QNRXBanner chart's image
180 Life Sciences
Price$0.88
Change-$0.12 (-12.00%)
Volume$100
Capitalization3.18M
Quoin Pharmaceuticals
Price$0.25
Change-$0.04 (-13.79%)
Volume$8.91K
Capitalization6.02M
ATNF vs QNRX Comparison Chart
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. QNRX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a Hold and QNRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ATNF: $1.00 vs. QNRX: $0.29)
Brand notoriety: ATNF and QNRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 18% vs. QNRX: 2104%
Market capitalization -- ATNF: $2.8M vs. QNRX: $5.35M
ATNF [@Biotechnology] is valued at $2.8M. QNRX’s [@Biotechnology] market capitalization is $5.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whileQNRX’s FA Score has 2 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • QNRX’s FA Score: 2 green, 3 red.
According to our system of comparison, QNRX is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 5 TA indicator(s) are bullish while QNRX’s TA Score has 4 bullish TA indicator(s).

  • ATNF’s TA Score: 5 bullish, 3 bearish.
  • QNRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATNF is a better buy in the short-term than QNRX.

Price Growth

ATNF (@Biotechnology) experienced а -5.66% price change this week, while QNRX (@Biotechnology) price change was -0.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

ATNF is expected to report earnings on Mar 01, 2023.

QNRX is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNRX($6.02M) has a higher market cap than ATNF($3.18M). ATNF YTD gains are higher at: -45.055 vs. QNRX (-55.048). ATNF has higher annual earnings (EBITDA): -2.99M vs. QNRX (-8.55M). QNRX has more cash in the bank: 10.3M vs. ATNF (195K). ATNF has less debt than QNRX: ATNF (3.26M) vs QNRX (6.21M). ATNF (0) and QNRX (0) have equivalent revenues.
ATNFQNRXATNF / QNRX
Capitalization3.18M6.02M53%
EBITDA-2.99M-8.55M35%
Gain YTD-45.055-55.04882%
P/E Ratio0.13N/A-
Revenue00-
Total Cash195K10.3M2%
Total Debt3.26M6.21M52%
FUNDAMENTALS RATINGS
ATNF vs QNRX: Fundamental Ratings
ATNF
QNRX
OUTLOOK RATING
1..100
496
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9196
P/E GROWTH RATING
1..100
961
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNRX's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for ATNF (57) in the Financial Conglomerates industry. This means that QNRX’s stock grew somewhat faster than ATNF’s over the last 12 months.

QNRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that QNRX’s stock grew similarly to ATNF’s over the last 12 months.

QNRX's SMR Rating (99) in the Biotechnology industry is in the same range as ATNF (99) in the Financial Conglomerates industry. This means that QNRX’s stock grew similarly to ATNF’s over the last 12 months.

ATNF's Price Growth Rating (91) in the Financial Conglomerates industry is in the same range as QNRX (96) in the Biotechnology industry. This means that ATNF’s stock grew similarly to QNRX’s over the last 12 months.

QNRX's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ATNF (96) in the Financial Conglomerates industry. This means that QNRX’s stock grew significantly faster than ATNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNFQNRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 18 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USAC27.690.50
+1.84%
USA Compression Partners LP
UNFI28.060.42
+1.52%
United Natural Foods
DT48.370.54
+1.13%
Dynatrace
OPAL1.62-0.08
-4.71%
OPAL Fuels
ESGL1.90-0.10
-4.96%
ESGL Holdings Limited

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
+5.26%
PRQR - ATNF
56%
Loosely correlated
+6.20%
KRRO - ATNF
43%
Loosely correlated
+8.71%
WVE - ATNF
41%
Loosely correlated
-2.20%
JSPR - ATNF
41%
Loosely correlated
+2.17%
XAGE - ATNF
38%
Loosely correlated
+4.60%
More

QNRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with ATNF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then ATNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
+38.23%
ATNF - QNRX
36%
Loosely correlated
+5.26%
ATNM - QNRX
35%
Loosely correlated
+2.01%
PRQR - QNRX
31%
Poorly correlated
+6.20%
WVE - QNRX
31%
Poorly correlated
-2.20%
MRNA - QNRX
28%
Poorly correlated
+2.06%
More